Selective control of synaptic plasticity in heterogeneous networks through transcranial alternating current stimulation (tACS).
Aref ParizDaniel TrotterAxel HuttJeremie LefebvrePublished in: PLoS computational biology (2023)
Transcranial alternating current stimulation (tACS) represents a promising non-invasive treatment for an increasingly wide range of neurological and neuropsychiatric disorders. The ability to use periodically oscillating electric fields to non-invasively engage neural dynamics opens up the possibility of recruiting synaptic plasticity and to modulate brain function. However, despite consistent reports about tACS clinical effectiveness, strong state-dependence combined with the ubiquitous heterogeneity of cortical networks collectively results in high outcome variability. Introducing variations in intrinsic neuronal timescales, we explored how such heterogeneity influences stimulation-induced change in synaptic connectivity. We examined how spike timing dependent plasticity, at the level of cells, intra- and inter-laminar cortical networks, can be selectively and preferentially engaged by periodic stimulation. Using leaky integrate-and-fire neuron models, we analyzed cortical circuits comprised of multiple cell-types, alongside superficial multi-layered networks expressing distinct layer-specific timescales. Our results show that mismatch in neuronal timescales within and/or between cells-and the resulting variability in excitability, temporal integration properties and frequency tuning-enables selective and directional control on synaptic connectivity by tACS. Our work provides new vistas on how to recruit neural heterogeneity to guide brain plasticity using non-invasive stimulation paradigms.
Keyphrases
- resting state
- single cell
- induced apoptosis
- white matter
- functional connectivity
- cerebral ischemia
- cell cycle arrest
- systematic review
- endoplasmic reticulum stress
- oxidative stress
- stem cells
- blood brain barrier
- brain injury
- cell therapy
- working memory
- signaling pathway
- electronic health record
- cell death
- combination therapy
- cell proliferation
- reduced graphene oxide